Detailansicht

Wissensnetz

Person

Philipp Beckhove (1969-)

Arzt

Name	Philipp Beckhove
Zeit	1969- (Lebensdaten)
Ort	Regensburg (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Arzt (charakteristischer Beruf)
Variante	P. Beckhove
Beziehung	Nationales Centrum für Tumorerkrankungen Deutsches Krebsforschungszentrum
Weitere Angaben	Diss. Medizinische Fakultät; Leiter der Arbeitsgruppe „Zelluläre Immuntherapie“ in der Abteilung Zelluläre Immunologie am DKFZ; Apl. Professor, Biowissenschaftliche Fakultät, Universität Heidelberg; Leiter Translationale Immunologie, NCT, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	121272842
Datensatz-ID	121272842
Beteiligt an alle anzeigen Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis A high-throughput RNAi screening identifies olfactory receptor signaling as a novel immune checkpoint in solid tumors A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma A screening for novel immune modulators identifies SIK3 kinase as a regulator of tumor resistance to T cell attack Induction of autoreactive regulatory T cells through promiscuous gene expression by bone marrow-resident plasma cells Identifizierung Tumorstroma-assoziierter T-Zellantigene in Plattenepithelkarzinomen des oberen Aerodigestivtrakts Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1 Identification of regulators of mutant p53 accumulation in lymphoma using RNA interference Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment Molecular Mechanisms of Macrophage Activation Induced by the Synergistic Effects of Low Dose Irradiation and Adoptive T Cell Therapy Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study Identification of novel tumor-associated immune modulators using a high-throughput RNAi screen Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study PI3K/AKT signaling is essential for communication between tissue infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients Untersuchungen zur zellulären Tumor-Immuntherapie : Migration von transferierten Immunzellen in Milz und Lebermetastasen, Bedeutung einzelner Lymphozytenpopulationen für die Tumorabstoßung

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Philipp Beckhove (1969-)

Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis

A high-throughput RNAi screening identifies olfactory receptor signaling as a novel immune checkpoint in solid tumors

A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma

A screening for novel immune modulators identifies SIK3 kinase as a regulator of tumor resistance to T cell attack

Induction of autoreactive regulatory T cells through promiscuous gene expression by bone marrow-resident plasma cells

Identifizierung Tumorstroma-assoziierter T-Zellantigene in Plattenepithelkarzinomen des oberen Aerodigestivtrakts

Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens

Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1

Identification of regulators of mutant p53 accumulation in lymphoma using RNA interference

Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone

POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment

Molecular Mechanisms of Macrophage Activation Induced by the Synergistic Effects of Low Dose Irradiation and Adoptive T Cell Therapy

Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone

Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study

Identification of novel tumor-associated immune modulators using a high-throughput RNAi screen

Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial

Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study

PI3K/AKT signaling is essential for communication between tissue infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer

Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer

A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer

Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer

Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients

Untersuchungen zur zellulären Tumor-Immuntherapie : Migration von transferierten Immunzellen in Milz und Lebermetastasen, Bedeutung einzelner Lymphozytenpopulationen für die Tumorabstoßung